ArticleSurgical oncology insight2025

Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapy.

Michael J Kirsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.